SAN FRANCISCO and MILANO,
Italy, March 22, 2018
/PRNewswire/ -- Trianni, Inc. ("TRIANNI") and Enthera, S.r.L.
("ENTHERA") jointly announced today that ENTHERA has entered into a
license agreement for The Trianni Mouse™, a best-in-class
monoclonal antibody discovery platform.
"TRIANNI is pleased to add ENTHERA as an important new
licensee," stated Dr. David
Meininger, TRIANNI's Chief Business Officer. "TRIANNI
continues to innovate to the benefit of our growing list of
partners. We're excited to enable ENTHERA's antibody discovery
efforts through this agreement."
"We are confident that the access to TRIANNI's technology
will dramatically improve our discovery efforts. It is a real
pleasure entering into this collaboration," declared Prof.
Paolo Fiorina, Chief Scientific
Officer at Enthera.
No financial details were disclosed.
About Trianni, Inc.
Trianni, Inc. is a privately held
biotech company specializing in antibody discovery technology.
TRIANNI's lead technology, The Trianni Mouse™, is a powerful,
next-generation platform enabling efficient generation of
fully-human monoclonal antibodies. TRIANNI's transgenic
platform leverages a novel approach to design made possible by
advances in DNA synthesis and genomic modification technology
making it a best-in-class therapeutic antibody discovery
platform. The company is headquartered in San Francisco, CA. Additional information
about TRIANNI is available through its corporate
website, www.trianni.com.
About Enthera, S.r.L.
Enthera S.r.l. is a new Italian biotech start-up which mission is
to find new therapeutic approaches to treat diabetes and related
gastrointestinal complication (enteropathy), as well as other
intestinal disorders sharing the same biological pathway. Its name
comes from the crasis of the
terms entero (referring to the intestine) and
therapy.
Enthera was founded by BiovelocITA in October 2016 in collaboration with the
scientists: Prof. Paolo Fiorina and
Dr. Francesca D'Addio.
Contacts: TRIANNI
Mandy
Boyd
Director of Marketing
1.415.231.0256 [o]
1.866.674.9314
mandy.boyd@trianni.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/enthera-and-trianni-announce-licensing-agreement-300617704.html
SOURCE Trianni, Inc.